|
|
|
|
|
Current
Neuro-Oncology
|
|
|
|
Volume
23 Number 7
15 April 2021
|
|
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
23, Year 2021 >
Number 7, 15 April
|
|
|
|
|
*
|
Dissaux
G, Dissaux B, Bourhis D, Schick U, Querellou S.
18F-FET
PET/CT in Early Subventricular Zone Recurrence of Adult
Glioblastoma.
Clin
Nucl Med. 2021 Apr 1∟.
doi: 10.1097/RLU.0000000000003639∟.
PMID: 33795588∟.
Case report˰ ˍ
|
|
|
|
Filizoglu
N, Oksuzoglu K, Ozguven S.
Distinguishing
Meningioma From
Metastasis
of Prostate Cancer on 68Ga-PSMA
PET/CT.
Clin
Nucl Med. 2021 Apr 1, 2021;46(11):e553-e555∟.
doi: 10.1097/RLU.0000000000003629∟.
PMID: 34606488∟.
Case report˰ ˍ
|
|
|
|
Liu
S, Liu Y, Li G, Feng J, Chen L, Qiu X.
High-dose
radiation associated with improved survival in IDH-wildtype
low-grade glioma.
Chin
Neurosurg J. 2021 Apr 1, 2021;7(1):22∟.
doi: 10.1186/s41016-021-00239-z∟.
PMID: 33795023∟.
Observational study. ˍ
|
|
|
|
Tomei
S, Volontè A, Ravindran S, Mazzoleni S, Wang E, Galli R,
Maccalli C.
MicroRNA
Expression Profile Distinguishes Glioblastoma Stem Cells from
Differentiated Tumor Cells.
J
Pers Med. 2021 Apr 1, 2021;11(4):264∟.
doi: 10.3390/jpm11040264∟
PMID:
33916317∟.
Laboratory investigation. ˍ
|
|
|
|
Cai
JW, Chen XY, Chen JY, Wu ZY, Wu XY, Yu LH, You HH.
Glioblastoma
in a female neurofibromatosis 1 patient without IDH1, BRAF V600E,
and TERT promoter mutations: A case report.
Medicine
(Baltimore). 2021 Apr 2, 2021;100(13):e25346∟.
doi: 10.1097/MD.0000000000025346∟.
PMID: 33787635∟.
Case report. ˍ
|
|
|
|
Rahman
A, Lozada-Martinez ID, Rahman S, Ataullah AHM, Muñoz-Baez
K, Moscote-Salazar LR, Agrawal A, Rahman MM.
Letter:
A Phase II and Pharmacodynamic Trial of RO4929097 for Patients
With Recurrent/Progressive Glioblastoma.
Neurosurgery.
2021 Apr 2, 2021:nyab097∟.
doi: 10.1093/neuros/nyab097∟.
PMID: 33822209∟.
Comment. ˍ
Refers
to: Peereboom
DM, et al., A Phase II and Pharmacodynamic Trial of RO4929097 for
Patients With Recurrent/Progressive Glioblastoma.
Neurosurgery.
2020 Oct 7, 2021;88(2):246-251∟.
doi:
10.1093/neuros/nyaa412∟.
PMID:
33027815∟.
Interventional
study.
ˍ
ˍ
|
|
|
|
Jazmati
D, Steinmeier T, Ahamd Khalil D, Frisch S, Peters S, Schulze
Schleithoff S, Bäumer C, Rutkowski S, Frühwald MC, Blase
C, Tippelt S, Timmermann B.
Feasibility
of Proton Beam Therapy for Infants with Brain Tumours: Experiences
from the Prospective KiProReg Registry Study.
Clin
Oncol (R Coll Radiol). 2021 Apr 3, 2021;33(7):e295-e304∟.
doi: 10.1016/j.clon.2021.03.006∟.
PMID: 33820696∟.
Observational study. ˍ
|
|
|
|
Zheng
L, Zhou ZR, Shi M, Chen H, Yu QQ, Yang Y, Liu L, Zhang L, Guo Y,
Zhou X, Li C, Wei Q.
Nomograms
for predicting progression-free survival and overall survival
after surgery and concurrent chemoradiotherapy for glioblastoma: a
retrospective cohort study.
Ann
Transl Med. 2021 Apr 4, 2021;9(7):571∟.
doi: 10.21037/atm-21-673∟.
PMID: 33987269∟.
Observational study. ˍ
|
|
|
|
Casale
R, Lavrova E, Sanduleanu S, Woodruff HC, Lambin P.
Development
and external validation of a non-invasive molecular status
predictor of chromosome 1p/19q co-deletion based on MRI radiomics
analysis of Low Grade Glioma patients.
Eur
J Radiol. 2021 Apr 5, 2021;139:109678∟.
doi: 10.1016/j.ejrad.2021.109678∟.
PMID: 33848780∟.
Observational study. ˍ
|
|
|
|
Kertels
O, Breun M, Hänscheid H, Kircher M, Hartrampf PE, Schirbel A,
Monoranu CM, Ernestus RI, Buck AK, Löhr M, Matthies C, Lapa
C.
Peptide
Receptor Radionuclide Therapy in Patients With Neurofibromatosis
Type 2: Initial Experience.
Clin
Nucl Med. 2021 Apr 5∟.
doi: 10.1097/RLU.0000000000003627∟.
PMID: 33826573∟.
Observational study˰ ˍ
|
|
|
|
Yu
Y, Villanueva-Meyer J, Grimmer MR, Hilz S, Solomon DA, Choi S,
Wahl M, Mazor T, Hong C, Shai A, Phillips JJ, Wainer BH, McDermott
M, Haas-Kogan D, Taylor JW, Butowski N, Clarke JL, Berger MS,
Molinaro AM, Chang SM, Costello JF, Oberheim Bush
NA.
Temozolomide-induced
hypermutation is associated with distant recurrence and reduced
survival after high-grade transformation of low-grade IDH-mutant
gliomas.
Neuro
Oncol. 2021 Apr 5, 2021:noab081∟.
doi: 10.1093/neuonc/noab081∟.
PMID: 33823014∟.
Observational study. ˍ
|
|
|
|
Frappaz
D, Barritault M, Montané L, Laigle-Donadey F, Chinot O, Le
Rhun E, Bonneville-Levard A, Hottinger AF, Meyronnet D, Bidaux AS,
Garin G, Pérol D.
MEVITEM
- A Phase I/II of vismodegib + temozolomide vs temozolomide in
patients with recurrent/refractory medulloblastoma with Sonic
Hedgehog pathway activation.
Neuro
Oncol. 2021 Apr 7, 2021:noab087∟.
doi: 10.1093/neuonc/noab087∟.
PMID: 33825892∟.
Interventional study. ˍ
|
|
|
|
Lietke
S, Schmutzer M, Schwartz C, Weller J, Siller S, Aumiller M, Heckl
C, Forbrig R, Niyazi M, Egensperger R, Stepp H, Sroka R, Tonn JC,
Rühm A, Thon N.
Interstitial
Photodynamic Therapy Using 5-ALA for Malignant Glioma
Recurrences.
Cancers
(Basel). 2021 Apr 7, 2021;13(8):1767∟.
doi: 10.3390/cancers13081767∟.
PMID:
33917116∟.
Observational study. ˍ
|
|
|
|
Müller
DMJ, De Swart ME, Ardon H, Barkhof F, Bello L, Berger MS,
Bouwknegt W, Van den Brink WA, Conti Nibali M, Eijgelaar RS,
Furtner J, Han SJ, Hervey-Jumper S, Idema AJS, Kiesel B, Kloet A,
Mandonnet E, Robe PAJT, Rossi M, Sciortino T, Vandertop WP, Visser
M, Wagemakers M, Widhalm G, Witte MG, De Witt Hamer PC.
Timing
of glioblastoma surgery and patient outcomes: a multicenter cohort
study.
Neurooncol
Adv. 2021 Apr 8, 2021;3(1):vdab053∟.
doi: 10.1093/noajnl/vdab053∟.
PMID: 34056605∟.
Observational study. ˍ
|
|
|
|
Bernchou
U, Skak Tranemose Arnold T, Axelsen B, Klüver-Kristensen M,
Mahmood F, Severin Gråe Harbo F, Thor Asmussen J, Hansen O,
Smedegaard Bertelsen A, Hansen S, Brink C, Hedegaard Dahlrot
R.
Evolution
of the gross tumour volume extent during radiotherapy for
glioblastomas.
Radiother
Oncol. 2021 Apr 9,
2021;160:40-46∟.
doi: 10.1016/j.radonc.2021.04.001∟.
PMID: 33848564∟.
Interventional study. ˍ
|
|
|
|
Bobeff
K, Krajewska K, Baranska D, Kotulska K, Jozwiak S, Mlynarski W,
Trelinska J.
Maintenance
Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in
Patients With Tuberous Sclerosis - Final Results From the EMINENTS
Study.
Front
Neurol. 2021 Apr 9, 2021;12:581102∟.
doi:10.3389/fneur.2021.581102∟.
PMID: 33897576∟.
Interventional study. ˍ
|
|
|
|
On
J, Natsumeda M, Watanabe J, Saito S, Kanemaru Y, Abe H, Tsukamoto
Y, Okada M, Oishi M, Yoshimura J, Kakita A, Fujii Y.
Low
Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained
from Lumbar Puncture in Newly Diagnosed Diffuse Midline
Gliomas.
Diagnostics
(Basel). 2021 Apr 9, 2021;11(4):681∟.
doi: 10.3390/diagnostics11040681∟.
PMID: 33918936∟.
Observational study. ˍ
|
|
|
|
Pasquini
L, Napolitano A, Tagliente E, Dellepiane F, Lucignani M, Vidiri A,
Ranazzi G, Stoppacciaro A, Moltoni G, Nicolai M, Romano A, Di
Napoli A, Bozzao A.
Deep
Learning Can Differentiate IDH-Mutant from IDH-Wild GBM.
J
Pers Med. 2021 Apr 9, 2021;11(4):290∟.
doi: 10.3390/jpm11040290∟.
PMID: 33918828∟.
Observational study. ˍ
|
|
|
|
Sinai
Khandeparkar SG, Gosavi SS, Gogate BP, Talathi N.
A
rare case of cerebellar pilomyxoid astrocytoma associated with
neurofibromatosis-1 in a young female; case report highlighting
immunohistochemical features.
Indian
J Pathol Microbiol. 2021 Apr 9, 2021;64(2):354-357∟.
doi: 10.4103/IJPM.IJPM_209_20(?).
PMID: 33851634∟.
Case report. ˍ
|
|
|
|
Zhao
M, Fu X, Zhang Z, Li A, Wang X, Li X.
Intracranial
131I-chTNT Brachytherapy in Patients with Deep-Seated Glioma: A
Single-center Experience with 10-Year Follow-up from
China.
Nuklearmedizin.
2021 Apr 9∟.
doi: 10.1055/a-1429-1967∟.
PMID: 33836553∟.
Observational study˰ ˍ
|
|
|
|
Friedman
GK, Johnston JM, Bag AK, Bernstock JD, Li R, Aban I, Kachurak K,
Nan L, Kang KD, Totsch S, Schlappi C, Martin AM, Pastakia D,
McNall-Knapp R, Farouk Sait S, Khakoo Y, Karajannis MA, Woodling
K, Palmer JD, Osorio DS, Leonard J, Abdelbaki MS, Madan-Swain A,
Atkinson TP, Whitley RJ, Fiveash JB, Markert JM, Gillespie
GY.
Oncolytic
HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.
N
Engl J Med. 2021 Apr 10∟.
doi: 10.1056/NEJMoa2024947∟.
PMID: 33838625∟.
Interventional study. ˍ
|
|
|
|
Hong
S, Sato K, Kagawa K, Ichi S.
The
long-term outcome of CyberKnife-based stereotactic radiotherapy
for central skull base meningiomas: a single-center
experience.
Neurosurg
Rev. 2021 Apr 10∟.
doi: 10.1007/s10143-021-01535-z∟.
PMID: 33839946∟.
Observational study. ˍ
|
|
|
*
|
Levy
AS, Krailo M, Chi S, Villaluna D, Springer L, Williams-Hughes C,
Fouladi M, Gajjar A.
Temozolomide
with irinotecan versus temozolomide, irinotecan plus bevacizumab
for recurrent medulloblastoma of childhood: Report of a COG
randomized Phase II screening trial.
Pediatr
Blood Cancer. 2021 Apr 12, 2021:e29031∟.
doi: 10.1002/pbc.29031∟.
PMID: 33844469∟.
Interventional study. ˍ
|
|
|
|
Baldovin
M, Saratziotis A, Munari S, Emanuelli E.
Diagnosis
and treatment of congenital nasal glioma.
BMJ
Case Rep. 2021 Apr 13, 2021;14(4):e242138∟.
doi: 10.1136/bcr-2021-242138∟.
PMID: 33849883∟.
Case report. ˍ
|
|
|
|
Sato
H, Mizumoto M, Okumura T, Sakurai H, Sakamoto N, Akutsu H,
Ishikawa E, Tsuboi K.
Long-term
outcomes of patients with unresectable benign meningioma treated
with proton beam therapy.
J
Radiat Res. 2021 Apr 13, 2021:rrab017∟.
doi: 10.1093/jrr/rrab017∟.
PMID: 33855438∟.
Observational study. ˍ
|
|
|
|
Wang
Y, Xu J, Luo N, Qi C, Tao R.
Successful
treatment of an adult patient with diffuse midline glioma
employing olaparib combined with bevacizumab.
Invest
New Drugs. 2021 Apr 13∟.
doi: 10.1007/s10637-021-01116-3∟.
PMID: 33851364∟.
Case report. ˍ
|
|
|
|
Pan
SP, Zheng XL, Zhang N, Lin XM, Li KJ, Xia XF, Zou CL, Zhang WY.
A
novel nomogram for predicting the risk of epilepsy occurrence
after operative in gliomas patients without preoperative epilepsy
history.
Epilepsy
Res. 2021 Apr 14, 2021;174:106641∟.
doi: 10.1016/j.eplepsyres.2021.106641∟.
PMID: 33878595∟.
Observational study. ˍ
|
|
|
|
Gangoso
E, Southgate B, Bradley L, Rus S, Galvez-Cancino F, McGivern N,
Güç E, Kapourani CA, Byron A, Ferguson KM, Alfazema N,
Morrison G, Grant V, Blin C, Sou I, Marques-Torrejon MA, Conde L,
Parrinello S, Herrero J, Beck S, Brandner S, Brennan PM, Bertone
P, Pollard JW, Quezada SA, Sproul D, Frame MC, Serrels A, Pollard
SM.
Glioblastomas
acquire myeloid-affiliated transcriptional programs via epigenetic
immunoediting to elicit immune evasion.
Cell.
2021 2021 Apr 14, 2021;184(9):2454-2470.e26∟.
doi: 10.1016/j.cell.2021.03.023∟.
PMID: 33857425∟.
Laboratory investigation. ˍ
|
|
|
|
Goel
A, Vutha R, Shah A, Singh K, Goel N, Shenoy A, Rai S, Dandpat
S.
Large
lateral intraventricular tumors - Outcome of radical surgery.
J
Clin Neurosci. 2021 Apr 14, 2021;88:205-212∟.
doi: 10.1016/j.jocn.2021.03.040∟.
PMID: 33992185∟.
Observational study. ˍ
|
|
|
|
Vils
A, Bogowicz M, Tanadini-Lang S, Vuong D, Saltybaeva N, Kraft J,
Wirsching HG, Gramatzki D, Wick W, Rushing E, Reifenberger G,
Guckenberger M, Weller M, Andratschke N.
Radiomic
Analysis to Predict Outcome in Recurrent Glioblastoma Based on
Multi-Center MR Imaging From the Prospective DIRECTOR Trial.
Front
Oncol. 2021 Apr 14, 2021;11:636672∟.
doi: 10.3389/fonc.2021.636672∟.
PMID: 33937035∟.
Observational study. ˍ
|
|
|
|
Zhang
Y, Kim J, Andrews C, Archer E, Bursztyn L, Grabe H, Margolin E,
Sullivan S, Trobe J.
Visual
Outcomes in Surgically Treated Intracranial Meningiomas.
J
Neuroophthalmol. 2021 Apr 14∟.
doi: 10.1097/WNO.0000000000001205∟.
PMID: 33870941∟.
Observational study˰ ˍ
|
|
|
|
Królicki
L, Bruchertseifer F, Kunikowska J, Koziara H, Pawlak D, Kuliński
R, Rola R, Merlo A, Morgenstern A.
Dose
escalation study of targeted alpha therapy with
[225Ac]Ac-DOTA-substance
P in recurrence glioblastoma – safety and efficacy.
Eur
J Nucl Med Mol Imaging. 2021 Apr 15∟.
doi: 10.1007/s00259-021-05350-y∟.
PMID: 33860346∟.
Interventional study. ˍ
|
|
|
|
Talati
P, El-Abtah M, Kim D, Dietrich J, Fu M, Wenke M, He J, Natheir SN,
Vangel M, Rapalino O, Vaynrub A, Arrillaga-Romany I, Forst DA, Yen
YF, Andronesi O, Kalpathy-Cramer J, Rosen B, Batchelor TT,
Gonzalez RG, Gerstner ER, Ratai EM.
MR
spectroscopic imaging predicts early response to anti-angiogenic
therapy in recurrent glioblastoma.
Neurooncol
Adv. 2021 Apr 15, 2021;3(1):vdab060∟.
doi: 10.1093/noajnl/vdab060∟.
PMID: 34131648∟.
Observational study.ˍ
|
|
|
|
|
|
|
|
|
|
|